Overview

PD-1 Antibody for Reactive EBV After BMT

Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
PD-1 antibody for reactivation of EBV after transplantation in patients with CAEBV/EBV-HLH
Phase:
Early Phase 1
Details
Lead Sponsor:
Beijing Friendship Hospital